Read More Pharma Industry News Mirum Pharmaceuticals raises $120m to advance Maralixibat for rare liver diseases Mirum Pharmaceuticals, a clinical-stage pharmaceutical company, has successfully raised $120 million in a Series A funding round to… bypharmanewsdailyDecember 2, 2018
